Lincoln Alternative Strategies LLC Reports 5.42% Ownership in Bionano Genomics, Inc.

Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, reporting a 5.42% ownership stake in Bionano Genomics, Inc. The filing indicates that Lincoln Alternative Strategies LLC beneficially owns 525,000 shares of Bionano Genomics' common stock. The shares are held solely by Lincoln Alternative Strategies LLC, with no shared voting or dispositive power. The filing certifies that the shares were not acquired for the purpose of influencing the control of the issuer. The beneficial ownership percentage is based on 9,680,265 shares of Bionano Genomics' common stock issued and outstanding as of September 17, 2025.